Alzheimer’s disease research has made great advances in testing and imaging. Scientists are investigating a number of disease markers and diagnostic tests, which may accurately and reliably indicate whether a person has Alzheimer’s disease and how far it has progressed. Some of these tests use cutting-edge technology and are not widely available yet, so participation […]Read More
At some point in life, everyone will experience symptoms of brain aging. While your cognitive functioning may change as you get older, you can still take steps to keep your brain healthy as you age. Tips for Maintaining a Healthy Brain Exercise As well as helping you to sleep and feel better and more energized, […]Read More
What Are Clinical Trials? Clinical trials are research studies conducted to evaluate the safety and efficacy of a potential intervention or diagnostic tool. Each trial has specific criteria for participation, as well as a detailed protocol of assessments, timelines for participation, and drug administration (if applicable). Clinical intervention trials span an array of modalities or […]Read More
Scientists are exploring new types of medications to treat Alzheimer’s disease. The Green Memory study is novel, as it focuses on targeting the gut’s microbiome to determine if rebalancing certain bacteria with a naturally derived investigational medication would improve brain function and slow the progression of Alzheimer’s disease. This investigational medication has been approved for […]Read More
Cognitive health is being impacted by the COVID-19 pandemic. This could be due to a long-term effect of having had the virus, or the consequences of living through the pandemic. Older adults are particularly more vulnerable to the negative effects of social isolation, which can increase the likelihood of depression and anxiety, leading to decrease […]Read More
by Michelle Papka, Ph.D.
Alzheimer’s disease (AD) is a complicated disease process leading to a cascade of events in the brain. Based on an accumulation of research, it is believed that the initial trigger is an increase in a protein called abeta-42, referred to as amyloid beta. This protein sticks together and causes the formation of amyloid plaques that […]Read More